

Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
The global Bifidus market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淏ifidus Industry Forecast鈥 looks at past sales and reviews total world Bifidus sales in 2023, providing a comprehensive analysis by region and market sector of projected Bifidus sales for 2024 through 2030. With Bifidus sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bifidus industry.
This Insight Report provides a comprehensive analysis of the global Bifidus landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bifidus portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥 unique position in an accelerating global Bifidus market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bifidus and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bifidus.
United States market for Bifidus is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Bifidus is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Bifidus is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Bifidus players cover Chr-Hansen, DuPont, Wecare Probiotics, Probi, Mitushi Bio Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Bifidus market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Food Grade
Pharmaceutical Grade
Segmentation by Application:
Food & Beverages
Medicines
Health Products
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Chr-Hansen
DuPont
Wecare Probiotics
Probi
Mitushi Bio Pharma
Scitop Bio-tech
Lallemand
Goerlich Pharma
Shandong Zhongke Jiayi Bioengineering
Danone
Shanghai SPH Sinopharm
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bifidus market?
What factors are driving Bifidus market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bifidus market opportunities vary by end market size?
How does Bifidus break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Bifidus Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Bifidus by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Bifidus by Country/Region, 2019, 2023 & 2030
2.2 Bifidus Segment by Type
2.2.1 Food Grade
2.2.2 Pharmaceutical Grade
2.3 Bifidus Sales by Type
2.3.1 Global Bifidus Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Bifidus Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Bifidus Sale Price by Type (2019-2024)
2.4 Bifidus Segment by Application
2.4.1 Food & Beverages
2.4.2 Medicines
2.4.3 Health Products
2.4.4 Others
2.5 Bifidus Sales by Application
2.5.1 Global Bifidus Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Bifidus Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Bifidus Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Bifidus Breakdown Data by Company
3.1.1 Global Bifidus Annual Sales by Company (2019-2024)
3.1.2 Global Bifidus Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Bifidus Annual Revenue by Company (2019-2024)
3.2.1 Global Bifidus Revenue by Company (2019-2024)
3.2.2 Global Bifidus Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Bifidus Sale Price by Company
3.4 Key Manufacturers Bifidus Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bifidus Product Location Distribution
3.4.2 Players Bifidus Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Bifidus by Geographic Region
4.1 World Historic Bifidus 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Bifidus Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Bifidus Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Bifidus 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Bifidus Annual Sales by Country/Region (2019-2024)
4.2.2 Global Bifidus Annual Revenue by Country/Region (2019-2024)
4.3 Americas Bifidus Sales Growth
4.4 APAC Bifidus Sales Growth
4.5 Europe Bifidus Sales Growth
4.6 Middle East & Africa Bifidus Sales Growth
5 Americas
5.1 Americas Bifidus Sales by Country
5.1.1 Americas Bifidus Sales by Country (2019-2024)
5.1.2 Americas Bifidus Revenue by Country (2019-2024)
5.2 Americas Bifidus Sales by Type (2019-2024)
5.3 Americas Bifidus Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bifidus Sales by Region
6.1.1 APAC Bifidus Sales by Region (2019-2024)
6.1.2 APAC Bifidus Revenue by Region (2019-2024)
6.2 APAC Bifidus Sales by Type (2019-2024)
6.3 APAC Bifidus Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bifidus by Country
7.1.1 Europe Bifidus Sales by Country (2019-2024)
7.1.2 Europe Bifidus Revenue by Country (2019-2024)
7.2 Europe Bifidus Sales by Type (2019-2024)
7.3 Europe Bifidus Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bifidus by Country
8.1.1 Middle East & Africa Bifidus Sales by Country (2019-2024)
8.1.2 Middle East & Africa Bifidus Revenue by Country (2019-2024)
8.2 Middle East & Africa Bifidus Sales by Type (2019-2024)
8.3 Middle East & Africa Bifidus Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bifidus
10.3 Manufacturing Process Analysis of Bifidus
10.4 Industry Chain Structure of Bifidus
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bifidus Distributors
11.3 Bifidus Customer
12 World Forecast Review for Bifidus by Geographic Region
12.1 Global Bifidus 麻豆原创 Size Forecast by Region
12.1.1 Global Bifidus Forecast by Region (2025-2030)
12.1.2 Global Bifidus Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Bifidus Forecast by Type (2025-2030)
12.7 Global Bifidus Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Chr-Hansen
13.1.1 Chr-Hansen Company Information
13.1.2 Chr-Hansen Bifidus Product Portfolios and Specifications
13.1.3 Chr-Hansen Bifidus Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Chr-Hansen Main Business Overview
13.1.5 Chr-Hansen Latest Developments
13.2 DuPont
13.2.1 DuPont Company Information
13.2.2 DuPont Bifidus Product Portfolios and Specifications
13.2.3 DuPont Bifidus Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 DuPont Main Business Overview
13.2.5 DuPont Latest Developments
13.3 Wecare Probiotics
13.3.1 Wecare Probiotics Company Information
13.3.2 Wecare Probiotics Bifidus Product Portfolios and Specifications
13.3.3 Wecare Probiotics Bifidus Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Wecare Probiotics Main Business Overview
13.3.5 Wecare Probiotics Latest Developments
13.4 Probi
13.4.1 Probi Company Information
13.4.2 Probi Bifidus Product Portfolios and Specifications
13.4.3 Probi Bifidus Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Probi Main Business Overview
13.4.5 Probi Latest Developments
13.5 Mitushi Bio Pharma
13.5.1 Mitushi Bio Pharma Company Information
13.5.2 Mitushi Bio Pharma Bifidus Product Portfolios and Specifications
13.5.3 Mitushi Bio Pharma Bifidus Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Mitushi Bio Pharma Main Business Overview
13.5.5 Mitushi Bio Pharma Latest Developments
13.6 Scitop Bio-tech
13.6.1 Scitop Bio-tech Company Information
13.6.2 Scitop Bio-tech Bifidus Product Portfolios and Specifications
13.6.3 Scitop Bio-tech Bifidus Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Scitop Bio-tech Main Business Overview
13.6.5 Scitop Bio-tech Latest Developments
13.7 Lallemand
13.7.1 Lallemand Company Information
13.7.2 Lallemand Bifidus Product Portfolios and Specifications
13.7.3 Lallemand Bifidus Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Lallemand Main Business Overview
13.7.5 Lallemand Latest Developments
13.8 Goerlich Pharma
13.8.1 Goerlich Pharma Company Information
13.8.2 Goerlich Pharma Bifidus Product Portfolios and Specifications
13.8.3 Goerlich Pharma Bifidus Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Goerlich Pharma Main Business Overview
13.8.5 Goerlich Pharma Latest Developments
13.9 Shandong Zhongke Jiayi Bioengineering
13.9.1 Shandong Zhongke Jiayi Bioengineering Company Information
13.9.2 Shandong Zhongke Jiayi Bioengineering Bifidus Product Portfolios and Specifications
13.9.3 Shandong Zhongke Jiayi Bioengineering Bifidus Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shandong Zhongke Jiayi Bioengineering Main Business Overview
13.9.5 Shandong Zhongke Jiayi Bioengineering Latest Developments
13.10 Danone
13.10.1 Danone Company Information
13.10.2 Danone Bifidus Product Portfolios and Specifications
13.10.3 Danone Bifidus Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Danone Main Business Overview
13.10.5 Danone Latest Developments
13.11 Shanghai SPH Sinopharm
13.11.1 Shanghai SPH Sinopharm Company Information
13.11.2 Shanghai SPH Sinopharm Bifidus Product Portfolios and Specifications
13.11.3 Shanghai SPH Sinopharm Bifidus Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Shanghai SPH Sinopharm Main Business Overview
13.11.5 Shanghai SPH Sinopharm Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.